Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance Study of [14C]HS-10504 in Healthy Adult Male Chinese Participants
NCT07764705Phase 1Not yet recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Jul 2026
- Primary completion
- Sep 2026
01
Overview
Phase 1, open-label, single-arm trial of HS-10504, sponsored by Hansoh Pharmaceutical Group. Primary endpoints: Total radiorecovery and cumulative radiorecovery in urine and feces per time interval at Day 21, Percentage of major metabolites in human plasma, urine, and feces at Day 21 and 2 more. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
HS-10504
Beyond the preview
Go deeper on NCT07764705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07764705.